These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31662305)

  • 1. Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.
    van Bommel EJM; Ruiter D; Muskiet MHA; van Baar MJB; Kramer MHH; Nieuwdorp M; Joles JA; Bjornstad P; van Raalte DH
    Diabetes Care; 2020 Jan; 43(1):228-234. PubMed ID: 31662305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
    Tonneijck L; Muskiet MHA; Smits MM; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
    Diabetes Obes Metab; 2017 Dec; 19(12):1669-1680. PubMed ID: 28449402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
    Cherney DZ; Perkins BA; Soleymanlou N; Maione M; Lai V; Lee A; Fagan NM; Woerle HJ; Johansen OE; Broedl UC; von Eynatten M
    Circulation; 2014 Feb; 129(5):587-97. PubMed ID: 24334175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.
    Ott C; Jung S; Korn M; Kannenkeril D; Bosch A; Kolwelter J; Striepe K; Bramlage P; Schiffer M; Schmieder RE
    Cardiovasc Diabetol; 2021 Sep; 20(1):178. PubMed ID: 34481498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.
    van Baar MJB; van Bommel EJM; Smits MM; Touw DJ; Nieuwdorp M; Ten Kate RW; Joles JA; van Raalte DH
    J Diabetes Complications; 2022 Apr; 36(4):108166. PubMed ID: 35221224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
    van Bommel EJM; Muskiet MHA; van Baar MJB; Tonneijck L; Smits MM; Emanuel AL; Bozovic A; Danser AHJ; Geurts F; Hoorn EJ; Touw DJ; Larsen EL; Poulsen HE; Kramer MHH; Nieuwdorp M; Joles JA; van Raalte DH
    Kidney Int; 2020 Jan; 97(1):202-212. PubMed ID: 31791665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function.
    van Velzen DM; Smits MM; van Bommel EJM; Muskiet MHA; Tonneijck L; Kramer MHH; Joles JA; den Heijer M; Nokoff N; Bjornstad P; van Raalte DH
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1152-F1158. PubMed ID: 33900855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is GFR decline induced by SGLT2 inhibitor of clinical importance?
    Günes-Altan M; Bosch A; Striepe K; Bramlage P; Schiffer M; Schmieder RE; Kannenkeril D
    Cardiovasc Diabetol; 2024 May; 23(1):184. PubMed ID: 38811998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
    Lytvyn Y; Bjornstad P; Lovshin JA; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
    Am J Kidney Dis; 2019 Jun; 73(6):786-796. PubMed ID: 30799029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
    Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
    Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    Bjornstad P; Singh SK; Snell-Bergeon JK; Lovshin JA; Lytvyn Y; Lovblom LE; Rewers MJ; Boulet G; Lai V; Tse J; Cham L; Orszag A; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZI
    Diabetes Obes Metab; 2019 Mar; 21(3):575-583. PubMed ID: 30311395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.
    Cherney DZ; Reich HN; Miller JA; Lai V; Zinman B; Dekker MG; Bradley TJ; Scholey JW; Sochett EB
    Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R206-14. PubMed ID: 20410477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma uric acid and renal haemodynamics in type 2 diabetes patients.
    Suijk DL; Smits MM; Muskiet MH; Tonneijck L; Kramer MH; Joles JA; van Raalte DH
    Nephrology (Carlton); 2020 Apr; 25(4):290-297. PubMed ID: 31429150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes.
    Bjornstad P; Maahs DM; Cherney DZ; Cree-Green M; West A; Pyle L; Nadeau KJ
    Diabetes Care; 2014 Nov; 37(11):3033-9. PubMed ID: 25071077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
    Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M
    Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
    Miller JA; Curtis JR; Sochett EB
    Diabetes; 2003 Jul; 52(7):1806-11. PubMed ID: 12829650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
    Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
    Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort.
    Nerpin E; Risérus U; Ingelsson E; Sundström J; Jobs M; Larsson A; Basu S; Arnlöv J
    Diabetes Care; 2008 Aug; 31(8):1550-5. PubMed ID: 18509205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.